TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-15
DOI
10.1038/s41375-020-0864-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL
- (2019) Candace J. Poole et al. Epigenetics & Chromatin
- LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL
- (2019) Salma Parvin et al. CANCER CELL
- Distinct chromatin signatures of DNA hypomethylation in aging and cancer
- (2018) Raúl F. Pérez et al. AGING CELL
- Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
- (2018) M. Catherine Pietanza et al. JOURNAL OF CLINICAL ONCOLOGY
- High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts
- (2018) Jinghan Wang et al. EBioMedicine
- DNA Damage, Repair, and Cancer Metabolism
- (2018) Marc-Olivier Turgeon et al. Frontiers in Oncology
- PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non-small-cell lung cancer
- (2018) Yu Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- TET1 deficiency attenuates the DNA damage response and promotes resistance to DNA damaging agents
- (2017) Jonathan B. Coulter et al. Epigenetics
- TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells
- (2017) Nipun Verma et al. NATURE GENETICS
- The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
- (2017) Yu Liu et al. NATURE GENETICS
- PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma
- (2017) V Colicchia et al. ONCOGENE
- Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
- (2017) Xi Jiang et al. Nature Communications
- TET Methylcytosine Oxidases in T Cell and B Cell Development and Function
- (2017) Ageliki Tsagaratou et al. Frontiers in Immunology
- An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
- (2016) Donna L. Nile et al. BMC CANCER
- Role of TET enzymes in DNA methylation, development, and cancer
- (2016) Kasper Dindler Rasmussen et al. GENES & DEVELOPMENT
- Control of Foxp3 stability through modulation of TET activity
- (2016) Xiaojing Yue et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells
- (2016) Ageliki Tsagaratou et al. NATURE IMMUNOLOGY
- TET1 modulates H4K16 acetylation by controlling auto-acetylation of hMOF to affect gene regulation and DNA repair function
- (2016) Jianing Zhong et al. NUCLEIC ACIDS RESEARCH
- Biochemical reconstitution of TET1–TDG–BER-dependent active DNA demethylation reveals a highly coordinated mechanism
- (2016) Alain R. Weber et al. Nature Communications
- 5-Hydroxymethylcytosine Marks Sites of DNA Damage and Promotes Genome Stability
- (2016) Georgia Rose Kafer et al. Cell Reports
- 5-Hydroxymethylcytosine Remodeling Precedes Lineage Specification during Differentiation of Human CD4 + T Cells
- (2016) Colm E. Nestor et al. Cell Reports
- Tet Enzymes Regulate Telomere Maintenance and Chromosomal Stability of Mouse ESCs
- (2016) Jiao Yang et al. Cell Reports
- Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling
- (2015) Vincenzo Giambra et al. BLOOD
- Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis
- (2015) Min-Zu Wu et al. CANCER RESEARCH
- TET1 is a tumor suppressor of hematopoietic malignancy
- (2015) Luisa Cimmino et al. NATURE IMMUNOLOGY
- Acute loss of TET function results in aggressive myeloid cancer in mice
- (2015) Jungeun An et al. Nature Communications
- 5mC-hydroxylase activity is influenced by the PARylation of TET1 enzyme
- (2015) Fabio Ciccarone et al. Oncotarget
- Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice
- (2015) Zhigang Zhao et al. Cell Reports
- DNA repair mechanisms in cancer development and therapy
- (2015) Alessandro Torgovnick et al. Frontiers in Genetics
- Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription
- (2015) Fabio Ciccarone et al. Oncotarget
- Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages - strategies for data mining in support of therapeutic studies
- (2014) Melinda G Hollingshead et al. BMC GENOMICS
- Epigenetics in T-cell acute lymphoblastic leukemia
- (2014) Sofie Peirs et al. IMMUNOLOGICAL REVIEWS
- An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
- (2014) Birgit Knoechel et al. NATURE GENETICS
- ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells
- (2014) Stephen J. Roper et al. NUCLEIC ACIDS RESEARCH
- TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
- (2014) F Neri et al. ONCOGENE
- Global DNA hypomethylation in prostate cancer development and progression: a systematic review
- (2014) R Zelic et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- TET1 plays an essential oncogenic role in MLL-rearranged leukemia
- (2013) H. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dynamics of 5-Hydroxymethylcytosine and Chromatin Marks in Mammalian Neurogenesis
- (2013) Maria A. Hahn et al. Cell Reports
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
- (2011) Z. Li et al. BLOOD
- Early Relapse in ALL Is Identified by Time to Leukemia in NOD/SCID Mice and Is Characterized by a Gene Signature Involving Survival Pathways
- (2011) Lüder Hinrich Meyer et al. CANCER CELL
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
- (2011) Kelly Moran-Crusio et al. CANCER CELL
- Tet1 Is Dispensable for Maintaining Pluripotency and Its Loss Is Compatible with Embryonic and Postnatal Development
- (2011) Meelad M. Dawlaty et al. Cell Stem Cell
- Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells
- (2011) H. Wu et al. GENES & DEVELOPMENT
- Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia
- (2011) C Evangelisti et al. LEUKEMIA
- Genome-wide Regulation of 5hmC, 5mC, and Gene Expression by Tet1 Hydroxylase in Mouse Embryonic Stem Cells
- (2011) Yufei Xu et al. MOLECULAR CELL
- Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
- (2011) S. Ito et al. SCIENCE
- Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
- (2010) Torsten Haferlach et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification
- (2010) Shinsuke Ito et al. NATURE
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
- γ-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin
- (2008) Christophe E. Redon et al. ADVANCES IN SPACE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation